Soleno Therapeutics Statistics
Total Valuation
SLNO has a market cap or net worth of $1.45 billion. The enterprise value is $1.30 billion.
| Market Cap | 1.45B |
| Enterprise Value | 1.30B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SLNO has 36.41 million shares outstanding. The number of shares has increased by 283.26% in one year.
| Shares Outstanding | 36.41M |
| Shares Change (YoY) | +283.26% |
| Shares Change (QoQ) | +119.55% |
| Owned by Insiders (%) | 1.53% |
| Owned by Institutions (%) | 101.34% |
| Float | 15.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 10.09 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.23, with a Debt / Equity ratio of 0.00.
| Current Ratio | 11.23 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -61.80% and return on invested capital (ROIC) is -37.27%.
| Return on Equity (ROE) | -61.80% |
| Return on Assets (ROA) | -46.90% |
| Return on Capital (ROIC) | -37.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.58M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +845.95% in the last 52 weeks. The beta is -1.40, so SLNO's price volatility has been lower than the market average.
| Beta (5Y) | -1.40 |
| 52-Week Price Change | +845.95% |
| 50-Day Moving Average | 43.18 |
| 200-Day Moving Average | 37.20 |
| Relative Strength Index (RSI) | 42.39 |
| Average Volume (20 Days) | 669,952 |
Short Selling Information
The latest short interest is 3.36 million, so 9.22% of the outstanding shares have been sold short.
| Short Interest | 3.36M |
| Short Previous Month | 3.40M |
| Short % of Shares Out | 9.22% |
| Short % of Float | 21.26% |
| Short Ratio (days to cover) | 10.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -53.57M |
| Pretax Income | -52.03M |
| Net Income | -52.03M |
| EBITDA | -49.76M |
| EBIT | -52.03M |
| Earnings Per Share (EPS) | -$2.06 |
Balance Sheet
The company has $149.63 million in cash and $347,000 in debt, giving a net cash position of $149.28 million or $4.10 per share.
| Cash & Cash Equivalents | 149.63M |
| Total Debt | 347,000 |
| Net Cash | 149.28M |
| Net Cash Per Share | $4.10 |
| Equity (Book Value) | 143.39M |
| Book Value Per Share | 3.94 |
| Working Capital | 137.76M |
Cash Flow
In the last 12 months, operating cash flow was -$30.74 million and capital expenditures -$11,000, giving a free cash flow of -$30.75 million.
| Operating Cash Flow | -30.74M |
| Capital Expenditures | -11,000 |
| Free Cash Flow | -30.75M |
| FCF Per Share | -$0.85 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLNO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -283.26% |
| Shareholder Yield | -283.26% |
| Earnings Yield | -3.60% |
| FCF Yield | -2.13% |
Analyst Forecast
The average price target for SLNO is $60.33, which is 51.85% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.33 |
| Price Target Difference | 51.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 26, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 26, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |